Category: News
-
Defining, Not Receiving | Perspectives on Health Governance Reform in the Middle East & North Africa
This report brings MENA evidence and perspectives into the Global Health Architecture reform, highlighting the need for stronger civil society participation and a more inclusive, responsive and accountable approach to global health governance.
-
ITPC-MENA at AIDS 2026: A Region That Refuses to Stay in the Margins
At AIDS 2026 in Rio de Janeiro, ITPC-MENA brought MENA’s community evidence, priorities and perspectives into the global HIV conversation. From community-led monitoring and access to medicines to long-acting PrEP and strategic partnerships, the region made its priorities clear: MENA cannot be an afterthought in the global HIV response.
-
We’re on the Map: The MENA Roadmap to AIDS 2026
Every session where our region is represented, discussed, or defended — and where to find us in Rio. From 26 to 31 July, the XXIV International AIDS Conference (AIDS 2026) convenes in Rio de Janeiro under the theme Rethink. Rebuild. Rise. It gathers at the most financially uncertain moment the HIV response has faced — funding shrinking,…
-
Global Fund replenishment: the Gulf Cooperation Council (GCC) must announce its pledge before the next Board Meeting
Statement from 46 Organizations Wednesday, December 3rd, 2025 As the world faces unprecedented health challenges, the Middle East and North Africa (MENA) region is entering a critical phase marked by an accelerating health crisis. The region is experiencing the fastest-growing HIV epidemic globally, alongside a rising burden of tuberculosis and fragile health systems in several…
-
A Powerful Tribute to Professor Hakima Himmich: A Life of Courage, Justice, and Resistance
🗓️ On May 13, 2025, during the 3rd Global Summit on Intellectual Property and Access to Medicines (GSIPA2M2025) held in Marrakech and co-organized by ITPC-MENA, a deeply emotional moment captured the audience. A powerful tribute was paid to Professor Hakima Himmich, a true icon in the fight for health and social justice – in Morocco, across the MENA region, and far…
-
HIV PREVENTION & ACCOUNTABILITY: A MULTI-COUNTRY COMMUNITY PERSPECTIVE 2025
This report provides a civil society analysis of the HIV prevention response, outlining the progress and gaps in five countries: Egypt, Jordan, Lebanon, Morocco, and Tunisia. The findings inform a set of key recommendations aimed at addressing these urgent challenges and strengthening the response in MENA. DOWNLOAD PDF تنزيل ملف PDF TÉLÉCHARGER PDF Frontline AIDS…
-
The MENA H Coalition calls for sustained investments in the fight against tuberculosis in the MENA region
Joint press release FOR IMMEDIATE RELEASE MENA-H coalition urges urgent action to combat tuberculosis in the region, with emphasis on innovation and universal health coverage 2025, March 24 – On World Tuberculosis Day, the MENA-H Coalition issues an urgent call to intensify efforts to eliminate tuberculosis (TB) in the Middle East and North Africa (MENA)…
-
Results of a study on lenacapavir and two broadly neutralizing antibodies were presented at CROI 2025.
At the Conference on Retroviruses and Opportunistic Infections (CROI 2025) in San Francisco, results were presented from a Phase II study examining the efficacy of a combination of lenacapavir (TN Sunlenca) and two broadly neutralizing antibodies (bNAbs) – teropavimab and zinlirvimab. The study results indicate that this regimen could form the basis of a complete…
-
In Argentina, Gilead’s patent applications for lenacapavir have been rejected
The National Institute of Industrial Property of Argentina (INPI) has rejected patent applications from Gilead for the drug lenacapavir – an innovative long-acting injectable drug that has proven effective as an option for PrEP and the treatment of HIV with multi-drug resistance. Previously, the Argentine organization FGEP (Foundation for the Study and Research of Patent…
-
ViiV HEALTHCARE TO TRIPLE ANNUAL SUPPLY OF LONG-ACTING HIV PREP FOR LOW- AND MIDDLE-INCOME COUNTRIES: A REAL RACE IS STARTING AMONG PHARMACEUTICAL COMPANIES FOR MARKET SHARE AND PROFIT
Source : ITPC EECA Against the backdrop of a recent press release from Gilead announcing the signing of a voluntary license for the new drug lenacapavir, ViiV Healthcare has announced an increase in the supply of its injectable drug cabotegravir. This sequence of events inevitably raises the thought that a real race is starting among…